Anticancer activity of novel plant extracts from Trailliaedoxa gracilis (W. W. Smith and Forrest) in human carcinoid KRJ-I Cells.

B Svejda; Victor Aguiriano Moser; S Sturm; H Höger; E Ingolic; Veronika Siegl; H Stuppner; Roswitha Pfragner

Anticancer activity of novel plant extracts from Trailliaedoxa gracilis (W. W. Smith and Forrest) in human carcinoid KRJ-I Cells.

B Svejda
, Victor Aguiriano Moser
, S Sturm
, H Höger
, E Ingolic
, Veronika Siegl
, H Stuppner
, Roswitha Pfragner^* (Last author)

^*Corresponding author for this work

Division of Pathophysiology and Immunology

Research output: Contribution to journal › Research article

25 Citations (Web of Science)

Original language	English
Journal	Anticancer Research
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

302 Clinical Medicine
301 Medical-Theoretical Sciences, Pharmacy
106 Biology

Research Fields

Cancer Research
Neuroscience

Links

Cite this

@article{759160c5feec471fb3dafc5f4144e1c1,

title = "Anticancer activity of novel plant extracts from Trailliaedoxa gracilis (W. W. Smith and Forrest) in human carcinoid KRJ-I Cells.",

author = "B Svejda and \{Aguiriano Moser\}, Victor and S Sturm and H H{\"o}ger and E Ingolic and Veronika Siegl and H Stuppner and Roswitha Pfragner",

year = "2010",

language = "English",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

}

TY - JOUR

T1 - Anticancer activity of novel plant extracts from Trailliaedoxa gracilis (W. W. Smith and Forrest) in human carcinoid KRJ-I Cells.

AU - Svejda, B

AU - Aguiriano Moser, Victor

AU - Sturm, S

AU - Höger, H

AU - Ingolic, E

AU - Siegl, Veronika

AU - Stuppner, H

A2 - Pfragner, Roswitha

PY - 2010

Y1 - 2010

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000274537400007

UR - https://pubmed.ncbi.nlm.nih.gov/20150617

M3 - Research article

C2 - 20150617

SN - 0250-7005

JO - Anticancer Research

JF - Anticancer Research

ER -